Whole Blood Stimulation Assay as a Treatment Outcome Monitoring Tool for VL Patients in Ethiopia: A Pilot Evaluation

Prevalence of asymptomatic Leishmania infection and associated risk factors, after an outbreak in the south-western Madrid region, Spain, 2015

(2019) Ana Victoria Ibarra-Meneses et al.   Eurosurveillance

Asymptomatic immune responders to Leishmania among HIV positive patients

(2019) Laura Botana et al.   PLoS Neglected Tropical Diseases

Evaluation of methods for detection of asymptomatic individuals infected with Leishmania infantum in the state of Piauí, Brazil

(2019) Gabriane Nascimento Porcino et al.   PLoS Neglected Tropical Diseases

New insights into leishmaniasis in the immunosuppressed

(2018) Hannah Akuffo et al.   PLoS Neglected Tropical Diseases

Drug resistance and treatment failure in leishmaniasis: A 21st century challenge

(2017) Alicia Ponte-Sucre et al.   PLoS Neglected Tropical Diseases

IFN-γ, IL-2, IP-10, and MIG as Biomarkers of Exposure to Leishmania spp., and of Cure in Human Visceral Leishmaniasis

(2017) Ana V. Ibarra-Meneses et al.   Frontiers in Cellular and Infection Microbiology

Monocyte Chemotactic Protein 1 in Plasma from Soluble Leishmania Antigen-Stimulated Whole Blood as a Potential Biomarker of the Cellular Immune Response to Leishmania infantum

(2017) Ana V. Ibarra-Meneses et al.   Frontiers in Immunology

Cytokines and chemokines measured in dried SLA-stimulated whole blood spots for asymptomatic Leishmania infantum and Leishmania donovani infection

(2017) A. V. Ibarra-Meneses et al.   Scientific Reports

Interleukin-2 as a marker for detecting asymptomatic individuals in areas where Leishmania infantum is endemic

(2016) A.V. Ibarra-Meneses et al.   CLINICAL MICROBIOLOGY AND INFECTION

Regulation of immunity during visceral Leishmania infection

(2016) Vasco Rodrigues et al.   Parasites & Vectors

Successful Treatment of Human Visceral Leishmaniasis Restores Antigen-Specific IFN-γ, but not IL-10 Production

(2016) Emebet Adem et al.   PLoS Neglected Tropical Diseases

Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant Recipients

(2015) Eugenia Carrillo et al.   PLoS Neglected Tropical Diseases

Quantification of Leishmania infantum Kinetoplast DNA for Monitoring the Response to Meglumine Antimoniate Therapy in Visceral Leishmaniasis

(2013) Bahman Pourabbas et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Assessment of Interferon-γ Levels and Leishmanin Skin Test Results in Persons Recovered for Leishmaniasis

(2012) Mohammad H. Alimohammadian et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Reassessment of Immune Correlates in Human Visceral Leishmaniasis as Defined by Cytokine Release in Whole Blood

(2012) Om Prakash Singh et al.   Clinical and Vaccine Immunology

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

Immunodominant Antigens of Leishmania chagasi Associated with Protection against Human Visceral Leishmaniasis

(2012) Daniel R. Abánades et al.   PLoS Neglected Tropical Diseases

Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis

(2012) Om Prakash Singh et al.   PLoS Neglected Tropical Diseases

Visceral leishmaniasis: immunology and prospects for a vaccine

(2011) P.M. Kaye et al.   CLINICAL MICROBIOLOGY AND INFECTION

Interferon-Gamma Release Assay (Modified QuantiFERON) as a Potential Marker of Infection for Leishmania donovani, a Proof of Concept Study

(2011) Kamlesh Gidwani et al.   PLoS Neglected Tropical Diseases

Quantiferon-Leishmania as an Epidemiological Tool for Evaluating the Exposure to Leishmania Infection

(2010) Nevin Turgay et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Persistence ofLeishmania donovaniAntibodies in Past Visceral Leishmaniasis Cases in India

(2010) Kamlesh Gidwani et al.   Clinical and Vaccine Immunology

Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study

(2010) Ahmed M. Musa et al.   PLoS Neglected Tropical Diseases

Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases

(2009) T. A. Patel et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH